Cohort Study on Treatment of Cardiovascular Diseases With Traditional Chinese Medicine (CSCD-TCM plus)

Tianjin University of Traditional Chinese Medicine

Status: Enrolling

Conditions: Cardiovascular Diseases

Treatments: Drug: Chinese patent medicine

Study type: Observational

Funder types: Other

Identifiers

NCT05309343

CSCD-TCM plus

Details and patient eligibility

About

This is a cohort study performed in patients with cardiovascular diaeases who were treated with oral Chinese medicine and Western medicine. Collect indicators such as the incidence of cardiovascular events, all due to readmission, all due to death. To hospital using clinical samples to detect genomics, proteomics, metabolomics, intestinal flora and sclerotia.To explore the clinical efficacy of Chinese patent medicine in the treatment of cardiovascular diseases, and provide reliable data support for its clinical application.

Enrollment: 20,000 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

All patients admitted to the Department of Cardiovascular Medicine at The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, The Second Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin Chest Hospital, Tianjin Hospital of ITCWM Nankai Hospital and Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital were considered for inclusion in this study, and all Western medical diagnoses were identified and classified according to the International Classification of Diseases, 11th Revision (ICD-11).

Exclusion criteria

No exclusion criteria.

Trial design

20,000 participants in 2 patient groups

Exposed group

Description:

Western medicine treatment with Chinese medicine treatmen

Treatment:

Drug: Chinese patent medicine

Non-exposed group

Description:

Western medicine treatment